A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor.

A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor.

Detaylı Bibliyografya
Asıl Yazarlar:	Doran, M, Wordsworth, P, Bresnihan, B, Fitzgerald, O
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2001

Benzer Materyaller

Rheumatoid arthritis.
Yazar:: Wordsworth, P
Baskı/Yayın Bilgisi: (1992)

The immunogenetics of rheumatoid arthritis.
Yazar:: Wordsworth, P
Baskı/Yayın Bilgisi: (1990)

Anti-chromatin antibodies in juvenile rheumatoid arthritis
Yazar:: F. Ingegnoli, ve diğerleri
Baskı/Yayın Bilgisi: (2003-12-01)

The immunogenetics of rheumatoid arthritis.
Yazar:: Wordsworth, B, ve diğerleri
Baskı/Yayın Bilgisi: (1992)

Progress in the immunogenetics of rheumatoid arthritis.
Yazar:: Wordsworth, P
Baskı/Yayın Bilgisi: (1995)

Diagnostic value of Anti-CCP antibodies compared with Rheumatoid factor in Rheumatoid arthritis patients.
Yazar:: Hanaa N. Abdullah, ve diğerleri
Baskı/Yayın Bilgisi: (2013-08-01)

Genetic epidemiology of rheumatoid arthritis.
Yazar:: Harney, S, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
Yazar:: Nicole H. Trier, ve diğerleri
Baskı/Yayın Bilgisi: (2019-06-01)

Time to include fine specificity anti‐citrullinated protein antibodies in the routine diagnosis and management of rheumatoid arthritis?
Yazar:: Schwenzer, A, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Overlap between systemic sclerosis and rheumatoid arthritis: a distinct clinical entity?
Yazar:: Alex Magno Coelho Horimoto, ve diğerleri

Polygenic susceptibility in rheumatoid arthritis.
Yazar:: Wordsworth, B, ve diğerleri
Baskı/Yayın Bilgisi: (1991)

Antibody therapy for rheumatoid arthritis.
Yazar:: Taylor, P
Baskı/Yayın Bilgisi: (2003)

Antikeratin antibodies in rheumatoid arthritis
Yazar:: J Zabek
Baskı/Yayın Bilgisi: (2003-02-01)

Molecular genetics of rheumatoid arthritis.
Yazar:: Harney, S, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

ANTI-HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN B1 (ANTI-RA33) ANTIBODIES IN RHEUMATOID ARTHRITIS AND SYSTEMIC SCLEROSIS
Yazar:: P. A. Kuznetsova, ve diğerleri
Baskı/Yayın Bilgisi: (2017-04-01)

T cell genetics and rheumatoid arthritis (RA)
Yazar:: Wordsworth, P
Baskı/Yayın Bilgisi: (1998)

Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis
Yazar:: Stefano Alivernini, ve diğerleri
Baskı/Yayın Bilgisi: (2019-05-01)

The Diagnostic Utility of Anti-cyclic Citrullinated Peptide Antibodies, Matrix Metalloproteinase-3, Rheumatoid Factor, Erythrocyte Sedimentation Rate, and C-reactive Protein in Patients with Erosive and Non-erosive Rheumatoid Arthritis
Yazar:: O. Shovman, ve diğerleri
Baskı/Yayın Bilgisi: (2005-01-01)

Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (1994)

The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
Yazar:: Hui-Chun Yu, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Erosive polyarthritis in multicentric reticulohistiocytosis mimics rheumatoid arthritis
Yazar:: Bagus Putu Putra Suryana, ve diğerleri
Baskı/Yayın Bilgisi: (2018-02-01)

Comparism between Anti-RA33, Anti-CCP antibodies and Rheumatoid Factor in the Diagnosis of Rheumatoid Arthritis in Iraqi Patients
Yazar:: Ammar H. Al-Ubaidi, ve diğerleri
Baskı/Yayın Bilgisi: (2013-04-01)

Clinical features of rheumatoid arthritis
Yazar:: Colquhoun, M, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis
Yazar:: Nobuo Kuramoto, ve diğerleri
Baskı/Yayın Bilgisi: (2017-07-01)

Erosive arthritis and anti-cyclic citrullinated peptide antibodies in systemic sclerosis
Yazar:: A Abdessemed, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Anti-TNFa treatment in patients with rheumatoid arthritis and anti-Ro/SSA antibodies
Yazar:: P. Airò, ve diğerleri
Baskı/Yayın Bilgisi: (2011-09-01)

The prevalence and diagnostic performance of anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: The predictive and discriminative ability of serum antibody level in recognizing rheumatoid arthritis
Yazar:: Heidari Behzad, ve diğerleri
Baskı/Yayın Bilgisi: (2009-01-01)

Utility of anti-carbamylated protein antibodies in the diagnosis of early rheumatoid arthritis
Yazar:: Ashraf H Mohamed, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Clinical and etiological meaning of anti-carbamylated protein antibodies in rheumatoid arthritis
Yazar:: Shuichiro Nakabo
Baskı/Yayın Bilgisi: (2019-01-01)

Anti-neutrophil cytoplasmic antibody associated vasculitis in patients with rheumatoid arthritis
Yazar:: Haiting Wu, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Association of rheumatoid factor and anti-cyclic citrullinated peptide antibody with demographic, clinical, and inflammatory parameters in rheumatoid arthritis
Yazar:: Rajat Sarkar, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Relationship between bone mineral density and anti-citrullinated protein antibody and rheumatoid factor in patients with rheumatoid arthritis
Yazar:: Gökhan Sargın, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Rheumatoid factor versus anti - cyclic citrullinated peptide antibody as screening tool for rheumatoid arthritis in an ophthalmic clinic
Yazar:: Prabhakar Singh, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

HLA class II antigens in susceptibility to rheumatoid arthritis.
Yazar:: Wordsworth, B
Baskı/Yayın Bilgisi: (1991)

Distinct biomarkers for different bones in osteoporosis with rheumatoid arthritis
Yazar:: T. Tomizawa, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
Yazar:: Feldmann, M, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

Anti-cytokine therapy for rheumatoid arthritis.
Yazar:: Maini, R, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Evaluation of anti-citrullinated and anti-carbamylated antibodies in mexicans with rheumatoid arthritis and at-risk individuals
Yazar:: Edgar E. Lara-Ramírez, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
Yazar:: Isaacs, J, ve diğerleri
Baskı/Yayın Bilgisi: (1992)

Humanized monoclonal antibody treatment in rheumatoid arthritis.
Yazar:: Kyle, V, ve diğerleri
Baskı/Yayın Bilgisi: (1991)